Full-Time

Director – Vaccine Immunologist

Posted on 11/18/2024

Pfizer

Pfizer

10,001+ employees

Develops and manufactures vaccines and medicines

Social Impact
Biotechnology
Healthcare

Compensation Overview

$161.6k - $269.4kAnnually

+ Bonus

Senior, Expert

No H1B Sponsorship

New City, NY, USA

Relocation support available.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary
Requirements
  • PhD in Immunology or related field
  • 10 -15 years of post-graduate experience (preferably in industry)
  • Strong background in Immunology
  • Immunoassay development experience
  • Strong written and verbal communication skills
  • People Management Experience
  • Experience with vaccine clinical studies
  • Regulatory agency interaction experience
Responsibilities
  • Sets objectives for and manages multiple immunoassay development projects.
  • Collaborate as necessary with the appropriate leaders/scientists within Vaccine Research and Development to drive strategy for evaluation of vaccine-induced immune responses.
  • Interact with intra- and interdepartmental personnel in scientific discussions while advocating the appropriate clinical assays to address the scientific questions. The incumbent may also to lead or support external collaborations and/or technology transfers.
  • Immunology subject matter expert throughout assay lifecycle, including immunoassay qualification and/or validation.
  • Author publications relevant to the work being performed
  • Manage a diverse team of scientists at various levels
  • Write and review reports, technical documents and presentations to support assay development, qualification, validation and transfer.
  • Supervises laboratory staff including Managers.
  • Keep abreast of new scientific/ technology development by participating in scientific meetings/ seminars and through regular scientific review; in-house new technology/approaches as appropriate.
  • Quality: Ensure that Pfizer's values are reflected on a continuous basis in day-to-day job functions.

Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's operations is its partnership with BioNTech to develop a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also initiatives to ensure that vaccines reach underserved populations. The company's goal is to continuously expand its range of healthcare solutions while maintaining a commitment to improving public health.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Pfizer's investment in AI-driven drug discovery boosts its innovative capabilities.
  • The company's expansion into novel immunotherapies strengthens its oncology portfolio.
  • Strategic investments in cell therapy enhance Pfizer's position in advanced cancer treatments.

What critics are saying

  • Slowing demand for COVID-19 vaccines may impact Pfizer's revenue streams.
  • Activist investor involvement could pressure Pfizer into strategic shifts.
  • Increased competition in autoimmune and immunotherapy markets poses challenges to Pfizer's growth.

What makes Pfizer unique

  • Pfizer leads in biopharmaceutical innovation with a strong focus on vaccines and oncology.
  • The company collaborates with BioNTech, enhancing its COVID-19 vaccine development and distribution.
  • Pfizer's strategic investments in AI and epigenetics set it apart in drug discovery.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE